Download A Copy

The Board has accepted/approved the voluntary retirement of Mazi Sam Ohuabunwa, MON, the President/Chief Executive Officer of our company – Neimeth International Plc effective 31^st August 2011.

 Mazi Sam Ohuabunwa joined Pfizer Products Plc (as the company was then known) in 1978 and became the Managing Director, Chairman and Regional Manager (Pfizer West Africa) in 1993. 

In 1997, Sam led one of the earliest Management Buy Out Schemes in Corporate Nigeria to acquire Pfizer Inc’s 60% share holding in Pfizer Nigeria.  Following the acquisition, and Pfizer divestment, the name of the company was changed to Neimeth International Pharmaceuticals Plc and Sam became Chairman/CEO and later became President/CEO, relinquishing the office of the Chairman of the Board in line with good Corporate Governance practice.  Sam spent the following years leading the transformation of the company from total Dependence on Pfizer brands to total independence, having developed a full array of its own indigenous brands and products. 

It is remarkable that Sam admirably combined his responsibilities as Chief Executive Officer with leadership of various Private Sector Organization like the Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMGMAN), the Nigeria Employers Consultative Association (NECA) and the Nigerian Economic Summit Group (NESG) in an exceptional display of zeal and passion for the economic development of our nation. 

While we wish Sam an enjoyable retirement from Executive functions (As he will be retained in the Board in a non Executive capacity), we are pleased to announce the appointment of Mr Emmanuel Princewill Bamidele Ekunno as the Acting Managing Director/Chief Executive Officer of the company effective September 1, 2011.  Mr Ekunno joined Pfizer Products Plc in 1981 and has risen through several Management positions in Sales and Marketing to reach his current position as the Executive Vice President responsible for the Pharmaceutical Business.